Major Depressive Disorder in Iran: Epidemiology, Health Care Provision, Utilization, and Challenges

Area of Science:

• Public Health
• Mental Health Services Research
• Health Policy

Background:

• Major depressive disorder (MDD) is a leading cause of disability in Iran, affecting an estimated 12.5% of adults.
• A significant treatment gap exists, with approximately 60% of individuals with MDD receiving no treatment annually.
• Many cases remain undiagnosed or receive inadequate care, highlighting systemic issues.

Purpose of the Study:

• To critically review Iran's current healthcare structure for managing major depressive disorder (MDD).
• To analyze patterns of healthcare service utilization for MDD.
• To provide actionable recommendations for enhancing the quality of care for MDD patients in Iran.

Main Methods:

• Critical review of the existing healthcare system in Iran.
• Analysis of healthcare service utilization patterns for MDD.
• Examination of the roles and service quality of various healthcare professionals (psychiatrists, GPs, psychologists).
• Discussion of primary healthcare (PHC), health insurance, and inpatient care strengths and weaknesses.
• Consideration of contextual factors: mental health literacy, stigma, and healthcare inequity.

Main Results:

• Identified weaknesses in the current healthcare structure and service utilization for MDD in Iran.
• Highlighted challenges related to mental health literacy, stigma, and inequity in access to care.
• Assessed the contributions and limitations of different healthcare providers and systems (PHC, insurance, inpatient).

Conclusions:

• The current healthcare system in Iran faces significant challenges in effectively addressing the high burden of major depressive disorder (MDD).
• Improvements in mental health literacy, stigma reduction, and equitable access are crucial.
• Systemic changes and targeted recommendations are needed to enhance the quality and accessibility of MDD care.